Intranasal pirodavir (R77,975) treatment of rhinovirus colds.

A randomized, double-blind, placebo-controlled trial assessed the therapeutic efficacy of intranasal pirodavir in naturally occurring rhinovirus colds. Adults with symptoms of < or = 2 days' duration were randomly assigned to intranasal sprays of pirodavir (2 mg per treatment) or placebo six times d...

Disgrifiad llawn

Manylion Llyfryddiaeth

Cyhoeddwyd yn:	Antimicrob Agents Chemother
Prif Awduron:	Hayden, F G, Hipskind, G J, Woerner, D H, Eisen, G F, Janssens, M, Janssen, P A, Andries, K
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	American Society for Microbiology (ASM) 1995
Pynciau:	Research Article
Mynediad Ar-lein:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162529/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726484/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.290
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!